Health TidingsRemepy Advances Hybridopa Toward Phase III After Positive Parkinson’s Dis... Remepy Advances Hybridopa Toward Phase III After Positive Parkinson’s Dis... Read Post »
Health TidingsAttralus’ Zamubafusp Alfa Gets FDA Fast Track for AL Amyloidosis Attralus’ Zamubafusp Alfa Gets FDA Fast Track for AL Amyloidosis Read Post »
Health TidingsCan-Fite Advances Namodenoson in Liver Cancer and Piclidenoson in Psoriasis Can-Fite Advances Namodenoson in Liver Cancer and Piclidenoson in Psoriasis Read Post »
Health TidingsDefinium’s DT120 Meets All Key Endpoints in Phase 3 Voyage Trial for Gene... Definium’s DT120 Meets All Key Endpoints in Phase 3 Voyage Trial for Gene... Read Post »
Health TidingsAnnexon Adds Month 24 Endpoint to Phase 3 ARCHER II Trial of Vonaprument in... Annexon Adds Month 24 Endpoint to Phase 3 ARCHER II Trial of Vonaprument in... Read Post »
Health TidingsBelite Bio’s Tinlarebant Wins FDA Priority Review for Stargardt Disease Belite Bio’s Tinlarebant Wins FDA Priority Review for Stargardt Disease Read Post »
Health TidingsPDS Biotech Shifts Focus to PDS0301, Discontinues PDS0101 Phase 3 Program PDS Biotech Shifts Focus to PDS0301, Discontinues PDS0101 Phase 3 Program Read Post »
Health TidingsFDA Accepts Lonafarnib NDA for Chronic Hepatitis D, Advancing Potential Fir... FDA Accepts Lonafarnib NDA for Chronic Hepatitis D, Advancing Potential Fir... Read Post »
Health Tidings Mergers & AcquisitionsSentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Sentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Read Post »
Health TidingsObinutuzumab β Reduces Relapse Risk by 93.1% in Phase 3 Trial of AQP4-IgG-... Obinutuzumab β Reduces Relapse Risk by 93.1% in Phase 3 Trial of AQP4-IgG-... Read Post »
Health TidingsFDA Grants Fast Track Designation to AC Immune’s ACI-7104 for Parkinson D... FDA Grants Fast Track Designation to AC Immune’s ACI-7104 for Parkinson D... Read Post »
Health TidingsVaderis Launches Phase 3 Trial of Engasertib in HHT After $152 Million Fund... Vaderis Launches Phase 3 Trial of Engasertib in HHT After $152 Million Fund... Read Post »
Health TidingsFDA Rejects ITM-11 NDA Over CMC and Facility Issues FDA Rejects ITM-11 NDA Over CMC and Facility Issues Read Post »
Health TidingsSoligenix Discontinues HyBryte Development After Phase 3 FLASH2 Trial Halte... Soligenix Discontinues HyBryte Development After Phase 3 FLASH2 Trial Halte... Read Post »
Health TidingsAquestive Reports Improved Human Factors and Comparable PK for Anaphylm Ahe... Aquestive Reports Improved Human Factors and Comparable PK for Anaphylm Ahe... Read Post »
Health TidingsSionna’s SION-719 Fails Phase 2a Sweat Chloride Endpoint in Cystic Fibros... Sionna’s SION-719 Fails Phase 2a Sweat Chloride Endpoint in Cystic Fibros... Read Post »
Health Tidings Mergers & AcquisitionsSobi enters strategic partnership with Innate Pharma to license lacutamab i... Sobi enters strategic partnership with Innate Pharma to license lacutamab i... Read Post »
Health TidingsNicox Announces NCX 470 NDA Submission in China by Partner Ocumension Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension Read Post »
Health Tidings Mergers & AcquisitionsBeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia BeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia Read Post »
Health TidingsRiboX Advances First-in-Class CAR-T Therapy Designed to Generate CAR-T Cell... RiboX Advances First-in-Class CAR-T Therapy Designed to Generate CAR-T Cell... Read Post »
Health TidingsBioInvent’s BI-1808 Wins FDA Fast Track Designation for Ovarian Cancer BioInvent’s BI-1808 Wins FDA Fast Track Designation for Ovarian Cancer Read Post »
Health TidingsVedanta Biosciences Secures $60 Million to Advance Phase 3 VE303 Trial for ... Vedanta Biosciences Secures $60 Million to Advance Phase 3 VE303 Trial for ... Read Post »
Health TidingsNeurocrine Biosciences Advances Triple Receptor Obesity Therapy NBIP-‘... Neurocrine Biosciences Advances Triple Receptor Obesity Therapy NBIP-‘... Read Post »
Health Tidings Mergers & AcquisitionsEvotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Evotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Read Post »
Health Tidings Mergers & AcquisitionsOno and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Ono and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Read Post »
Health TidingsDutch Court Grants Novo Nordisk Preliminary Injunction Against Compounded S... Dutch Court Grants Novo Nordisk Preliminary Injunction Against Compounded S... Read Post »
Health TidingsNICE Recommends Acalabrutinib-Based Regimens as New First-Line Options for ... NICE Recommends Acalabrutinib-Based Regimens as New First-Line Options for ... Read Post »
Health TidingsMerck Wins FDA Review for ENFLONSIA Expansion in High-Risk Children Merck Wins FDA Review for ENFLONSIA Expansion in High-Risk Children Read Post »
Health TidingsFDA Approves Takeda’s ORZEYFUL, the First Orexin Therapy for Adults with ... FDA Approves Takeda’s ORZEYFUL, the First Orexin Therapy for Adults with ... Read Post »
Health TidingsIs Sustained Calorie Reduction the Key to Semaglutide’s Long-Term Wei... Is Sustained Calorie Reduction the Key to Semaglutide’s Long-Term Wei... Read Post »
Health TidingsSummit Launches HARMONi-GU1 Trial of Ivonescimab for First-Line Advanced Bl... Summit Launches HARMONi-GU1 Trial of Ivonescimab for First-Line Advanced Bl... Read Post »
Health TidingsExpedition Raises $115M to Advance EXPD-101 Phase 2 COPD Trial Expedition Raises $115M to Advance EXPD-101 Phase 2 COPD Trial Read Post »
GenericsZydus announces Final Approval from the USFDA for Indocyanine Green for Inj... Zydus announces Final Approval from the USFDA for Indocyanine Green for Inj... Read Post »
Health TidingsFDA Grants RMAT Designation to Lexeo’s LX2020 Gene Therapy for PKP2-A... FDA Grants RMAT Designation to Lexeo’s LX2020 Gene Therapy for PKP2-A... Read Post »
Health TidingsFDA Aligns with Tonix on Phase 2 Study Design for TNX-4800 to Prevent Lyme ... FDA Aligns with Tonix on Phase 2 Study Design for TNX-4800 to Prevent Lyme ... Read Post »
Health TidingsNurix Launches Phase 3 Trial of BTK Degrader Bexobrutideg Nurix Launches Phase 3 Trial of BTK Degrader Bexobrutideg Read Post »
Manufacturing Mergers & AcquisitionsFujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Fujifilm, Taiho Partner to Advance Manufacturing of Next-Gen ADCs Read Post »
Health TidingsRoutine Sodium Bicarbonate Fails to Improve Outcomes in Adult In-Hospital C... Routine Sodium Bicarbonate Fails to Improve Outcomes in Adult In-Hospital C... Read Post »
Health TidingsTavapadon Significantly Improved Motor Symptoms in Phase 3 Trial for Early ... Tavapadon Significantly Improved Motor Symptoms in Phase 3 Trial for Early ... Read Post »
Health Tidings Mergers & AcquisitionsEvexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Evexta Bio and Roche Partner on Phase 1b Trial of Rupitasertib Plus Giredes... Read Post »
Health TidingsAcurx Advances Ibezapolstat Toward Phase 3 Following Positive FDA Feedback Acurx Advances Ibezapolstat Toward Phase 3 Following Positive FDA Feedback Read Post »
Health TidingsFDA Supports Oculis’ Privosegtor for Acute Multiple Sclerosis Relapse... FDA Supports Oculis’ Privosegtor for Acute Multiple Sclerosis Relapse... Read Post »
GenericsFDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with Di... FDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with Di... Read Post »
Health TidingsGefurulimab PREVAIL Trial Shows Benefit in Generalized Myasthenia Gravis Gefurulimab PREVAIL Trial Shows Benefit in Generalized Myasthenia Gravis Read Post »
Health TidingsLilly Secures FDA Breakthrough Therapy Designation for Olomorasib in KRAS G... Lilly Secures FDA Breakthrough Therapy Designation for Olomorasib in KRAS G... Read Post »
Health TidingsZai Lab’s DLL3 ADC Zocilurtatug Pelitecan Receives FDA Orphan Drug Design... Zai Lab’s DLL3 ADC Zocilurtatug Pelitecan Receives FDA Orphan Drug Design... Read Post »
Health TidingsEvommune Advances Novel MRGPRX2 Therapy to Phase 2b for Migraine Evommune Advances Novel MRGPRX2 Therapy to Phase 2b for Migraine Read Post »
Health TidingsOtsuka Study Suggests S-Equol May Help Women With Severe PMS and PMDD Otsuka Study Suggests S-Equol May Help Women With Severe PMS and PMDD Read Post »
Health TidingsNovel Oral HIV Capsid Inhibitor VH-499 Reduces Viral Load in Phase 2a Study Novel Oral HIV Capsid Inhibitor VH-499 Reduces Viral Load in Phase 2a Study Read Post »
Health TidingsTiziana Reports Third Phase 2 MSA Patient Shows Reduced Neuroinflammation o... Tiziana Reports Third Phase 2 MSA Patient Shows Reduced Neuroinflammation o... Read Post »
